EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Relationship between ornithine decarboxylase activity and hexamethylene bisacetamide-induced differentiation of murine erythroleukemia cells


Experimental Cell Research 162(1): 142-150
Relationship between ornithine decarboxylase activity and hexamethylene bisacetamide-induced differentiation of murine erythroleukemia cells
A transitory increase in ornithine decarboxylase (ODC) activity is shown not to be a prerequisite for the differentiation induced by hexamethylene bisacetamide (HMBA) in murine erythroleukemic (MEL) cells. On the contrary, conditions are described, where inhibition of the ODC activity with alpha-difluoromethyl ornithine (DFMO) stimulated the induced differentiation. Polyamine analysis demonstrated that a reduction in intracellular putrescine and spermidine occurred in MEL cells before commitment to erythrodifferentiation. The presence of DFMO increased the rapidity and the amplitude of these changes. No effect of dexamethasone on these changes in ODC activity or intracellular polyamines was observed.

(PDF same-day service: $19.90)

Accession: 041221725

PMID: 3079592

DOI: 10.1016/0014-4827(86)90432-5



Related references

Proteomic analysis of erythroid differentiation induced by hexamethylene bisacetamide in murine erythroleukemia cells. Experimental Hematology 35(2): 193-202, 2007

Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells. Cancer Research 46(3): 1136-1141, 1986

Membrane alterations associated with hexamethylene bisacetamide hmba induced differentiation of murine erythroleukemia cells melc. Proceedings of the American Association for Cancer Research Annual Meeting 33: 50, 1992

Hexamethylene bisacetamide hmba induced reduction in diacylglycerol levels in associated with differentiation of murine erythroleukemia cells. Biomedicine & Pharmacotherapy 46(5-7): 298, 1992

Hexamethylene bisacetamide mediated protein kinase c translocation and activation during induced differentiation of murine erythroleukemia cells. Proceedings of the American Association for Cancer Research Annual Meeting 32: 76, 1991

Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells. Zhonghua Zhong Liu Za Zhi 13(4): 261-264, 1991

Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells. Cancer Research 37(2): 440-444, 1977

Synergistic action of activin A and hexamethylene bisacetamide in differentiation of murine erythroleukemia cells. Cancer Research 50(11): 3182-3185, 1990

Hexamethylene bisacetamide-induced differentiation of Friend virus-transformed murine erythroleukemia cells is associated with parallel changes in casein kinase II and guanine nucleotide exchange factor activities. Experimental Hematology 23(11): 1204-1211, 1995

Vincristine resistant murine erythroleukemia and hl 60 cells have marked sensitivity to induction of differentiation by hexamethylene bisacetamide. Proceedings of the American Association for Cancer Research Annual Meeting 30: 429, 1989